A Study Assessing HMB-002 in Participants With Von Willebrand Disease

Clinical trial NCT06754852 · RECRUITING

Trial details

NCT number: NCT06754852
Sponsor: Hemab ApS
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Von Willebrand Disease (VWD)Von Willebrand Disease (VWD), Type 1 Von Willebrand Disease (VWD), Type 2 Von Willebrand Disease (VWD), Type 3

Start date: 2025-02-06
Primary completion: 2027-07-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.